NCT02371668: A trial that was reported late by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported, although it was 19 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02371668 |
|---|---|
| Title | Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study in Healthy Volunteers to Evaluate the Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Human Challenge Model |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Feb. 25, 2015 |
| Completion date | Nov. 30, 2018 |
| Required reporting date | Nov. 30, 2019, midnight |
| Actual reporting date | Dec. 19, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 19 |